Area of research
Aerospace Engineering · Astronomy and Astrophysics
Research interest
Research focused on Drug and LAMOST, with related work in Clinical trial, Initialization, Rosuvastatin. Notable publications include 'The first data release (DR1) of the LAMOST regular survey', 'Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics', and 'Learning Feature Pyramids for Human Pose Estimation'.
Survey of Trajectory Optimization Methods for Mars Entry and Powered Descent
Deep Neural Networks Based Hypersonic Vehicle Reentry Impact Point Prediction With Fixed-Length Lightweight Training Data
A bidirectional interpretable compound-protein interaction prediction framework based on cross attention
Online Prediction and Correction of Static Voltage Stability Index Based on Extreme Gradient Boosting Algorithm
Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Indirect sequential convex programming for mars entry terminal altitude maximization
Mars Entry Tracking Guidance via Quadratically Constrained Quadratic Programming and Pseudospectral Method
Theoretical analysis and experimental research of photon-enhanced thermionic emission solar energy converters with InN photocathode
Saliency detection via double nuclear norm maximization and ensemble manifold regularization
Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non‐medullary thyroid carcinoma
Integrated guidance for Mars entry and powered descent using reinforcement learning and pseudospectral method
Studies on Three-Dimensional (3D) Modeling of UAV Oblique Imagery with the Aid of Loop-Shooting
Comparative Study on Solid-State and Metastable Liquid-State Aging for SAC305/Cu Joints
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
Learning Feature Pyramids for Human Pose Estimation
The first data release (DR1) of the LAMOST regular survey
Trends in Referral to Cardiac Rehabilitation After Myocardial Infarction
Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways